Amgen (NASDAQ:AMGN) declares $2.38/share quarterly dividend, 5.8% increase from prior dividend of $2.25. Forward yield 3.45% ...

The company now says that, during a recent meeting with the FDA, the two parties agreed on some key elements for an ...

For the past year, there has been a huge buzz about the so-called "weight loss injection". This is supposed to help people ...

The discontinuation of STRIDES is a rare stumble for the next-generation obesity field and comes just weeks after Amgen ...

Amgen has announced a $1bn investment to establish a second US drug substance manufacturing facility in North Carolina. The ...

The biotech disclosed Friday plans to terminate a Phase 2 study testing azelaprag with tirzepatide for weight loss following ...

Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...

It is not clear what specifically the new facility will produce, though Amgen could be ramping up its manufacturing capacity ...

Amgen (NASDAQ: AMGN) recently released clinical results for its developmental weight loss drug MariTide. Shares fell by as ...

We recently published a list of 12 Best Affordable Stocks To Buy Right Now. In this article, we are going to take a look at ...

With that let’s take a look at the 12 best affordable stocks to buy right now.

Wall Street is chewing over data on Amgen’s weight loss injection, MariTde. Meanwhile, GE HealthCare will acquire a Japanese ...